Singular Genomics Systems, Inc. (NasdaqCM: OMIC)
Health Care · Life Sciences Tools & Services · US
$—
— today · — 1Y
Singular Genomics Systems, Inc. (NasdaqCM: OMIC) operates in the Life Sciences Tools & Services industry within the Health Care sector.
Tweenvest scores Singular Genomics Systems, Inc. across four factors: quality 38/100, value 69/100. Its strongest factor is value.
OMIC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $2.67M
- P/E
- —
- EPS
- -34.77
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $—
- 52-week low
- $—
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 255
- Next earnings
- —
About Singular Genomics Systems, Inc.
Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.
- ISIN
- US82933R3084
- Founded
- 2016
- Listed since
- May 27, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| EVIO, Inc.OTCPK: EVIO | $20.73K | $0.00 | — |
| Telesis Bio, Inc.OTCPK: TBIO | $19.82K | $0.01 | +10900.00% |
| Quick-Med Technologies, Inc.OTCPK: QMDT | $18.67K | $— | — |
| 0913693 B.C. Ltd.OTCPK: REPC.F | $7.36K | $— | — |
| Arrayit CorporationOTCPK: ARYC | $1.13K | $0.00 | — |
| Response Genetics, IncOTCPK: RGDX.Q | $39.00 | $— | — |
| Deltagen Inc.OTCPK: DGEN | $33.00 | $— | — |
| BG Medicine, Inc.OTCPK: BGMD | $11.00 | $0.00 | — |
Figures last refreshed Oct 11, 2026.